Literature DB >> 11586470

Hepatic stellate cell behavior during resolution of liver injury.

J P Iredale1.   

Abstract

Acute self-limiting and chronic liver injury are both associated with activation and proliferation of hepatic stellate cells (HSCs). In chronic injury, activated stellate cells are the major source of the collagens that comprise fibrosis and cirrhosis, as well as of the tissue inhibitors of metalloproteinases (TIMPs) which inhibit collagen degradation. Recovery from acute and chronic injury is characterized by apoptosis of activated HSCs, which removes extracellular matrix-producing cells that are also expressing TIMPs, thereby relieving the inhibition of matrix degradation. HSC apoptosis is regulated in progressive injury and counterbalances cell proliferation. Apoptosis probably also represents a default pathway for the HSCs. The survival of activated HSCs in liver injury is dependent on soluble growth factors and cytokines, and on components of the fibrotic matrix. Additionally, stimulation of death receptors expressed on HSCs can precipitate their apoptosis. Our increasing understanding of the process of stellate cell behavior in recovery from injury is likely to be important to the design of antifibrotic therapies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11586470     DOI: 10.1055/s-2001-17557

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  104 in total

1.  Salvia miltiorrhiza monomer IH764-3 induces hepatic stellate cell apoptosis via caspase-3 activation.

Authors:  Xiao-Lan Zhang; Li Liu; Hui-Qing Jiang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

2.  Effects of herbal compound 861 on human hepatic stellate cell proliferation and activation.

Authors:  Lin Wang; Jian Wang; Bao-En Wang; Pei-Gen Xiao; Yan-Jiang Qiao; Xue-Hai Tan
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

3.  Morphologic features in the regenerating liver--a comparative intravital, lightmicroscopical and ultrastructural analysis with focus on hepatic stellate cells.

Authors:  Tymoteusz Budny; Daniel Palmes; Udo Stratmann; Evgeny Minin; Hermann Herbst; Hans-Ullrich Spiegel
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

4.  The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis.

Authors:  Haiyan Jin; Shuji Terai; Isao Sakaida
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

5.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

Authors:  Jeremy S Duffield; Stuart J Forbes; Christothea M Constandinou; Spike Clay; Marina Partolina; Srilatha Vuthoori; Shengji Wu; Richard Lang; John P Iredale
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

Review 6.  Anti-fibrogenic strategies and the regression of fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

7.  Kangxian ruangan keli inhibits hepatic stellate cell proliferation mediated by PDGF.

Authors:  Ling Yang; Chi-Zhi Zhang; Qing-Jing Zhu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  Dynamic expression of extracellular signal-regulated kinase in rat liver tissue during hepatic fibrogenesis.

Authors:  Xiao-Lan Zhang; Jin-Ming Liu; Chang-Chun Yang; Yi-Lin Zheng; Li Liu; Zhan-Kui Wang; Hui-Qing Jiang
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

Review 9.  Alcohol metabolites and lipopolysaccharide: roles in the development and/or progression of alcoholic liver disease.

Authors:  Courtney S Schaffert; Michael J Duryee; Carlos D Hunter; Bartlett C Hamilton; Amy L DeVeney; Mary M Huerter; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 10.  Treatment of hepatic fibrosis: almost there.

Authors:  Efsevia Albanis; Rifaat Safadi; Scott L Friedman
Journal:  Curr Gastroenterol Rep       Date:  2003-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.